Objectives The aim of this study was to test the hypothesis that a quadripolar left ventricular (LV) lead results in fewer LV lead-related events than a bipolar cardiac resynchronization therapy (CRT) system in a prospective randomized trial. Background Bipolar LV leads cannot be implanted at the optimal site in up to 10% of patients who need CRT, because of anatomic or technical challenges (pacing threshold, phrenic stimulation, or mechanical instability). Methods The MORE-CRT (More Options Available With a Quadripolar LV Lead Provide In-Clinic Solutions to CRT Challenges) trial enrolled 1,078 patients. Patients with indications for CRT defibrillator therapy were randomized into 2 groups in a 1:2 ratio: a group with a bipolar CRT lead system (the BiP group; any manufacturer) and a group with a quadripolar CRT system (the Quad group; Quartet LV lead). The primary endpoint was freedom from a composite endpoint of intraoperative and post-operative LV lead-related events at 6 months. Results A total of 1,074 of 1,078 patients (99%) were randomized and contributed to the primary endpoint. Freedom from the composite endpoint was significantly greater in the Quad than the BiP group (83.0% vs. 74.4%, p = 0.0002). The intraoperative component of the endpoint was met less frequently by Quad group patients (6.26% Quad vs. 12.1% BiP), whereas there was no difference for the post-operative component (7.1% Quad vs. 7.6% BiP). Conclusions The Quartet LV system significantly reduced total LV lead-related events at 6 months after implantation compared with a bipolar CRT system. The reduction in events demonstrates the superiority of this quadripolar technology to effectively manage CRT patients. (More Options Available With a Quadripolar LV Lead Provide In-Clinic Solutions to CRT Challenges [MORE-CRT]; NCT01510652).

Cardiac Resynchronization Therapy with a Quadripolar Electrode Lead Decreases Complications at 6 Months Results of the MORE-CRT Randomized Trial / Boriani, Giuseppe; Connors, Sean; Kalarus, Zbigniew; Lemke, Bernd; Mullens, Wilfried; Osca Asensi, Joaquin; Raatikainen, Pekka; Gazzola, Carlo; Farazi, Taraneh G.; Leclercq, Christophe. - In: JACC. CLINICAL ELECTROPHYSIOLOGY. - ISSN 2405-500X. - 2:2(2016), pp. 212-220. [10.1016/j.jacep.2015.10.004]

Cardiac Resynchronization Therapy with a Quadripolar Electrode Lead Decreases Complications at 6 Months Results of the MORE-CRT Randomized Trial

BORIANI, Giuseppe;
2016

Abstract

Objectives The aim of this study was to test the hypothesis that a quadripolar left ventricular (LV) lead results in fewer LV lead-related events than a bipolar cardiac resynchronization therapy (CRT) system in a prospective randomized trial. Background Bipolar LV leads cannot be implanted at the optimal site in up to 10% of patients who need CRT, because of anatomic or technical challenges (pacing threshold, phrenic stimulation, or mechanical instability). Methods The MORE-CRT (More Options Available With a Quadripolar LV Lead Provide In-Clinic Solutions to CRT Challenges) trial enrolled 1,078 patients. Patients with indications for CRT defibrillator therapy were randomized into 2 groups in a 1:2 ratio: a group with a bipolar CRT lead system (the BiP group; any manufacturer) and a group with a quadripolar CRT system (the Quad group; Quartet LV lead). The primary endpoint was freedom from a composite endpoint of intraoperative and post-operative LV lead-related events at 6 months. Results A total of 1,074 of 1,078 patients (99%) were randomized and contributed to the primary endpoint. Freedom from the composite endpoint was significantly greater in the Quad than the BiP group (83.0% vs. 74.4%, p = 0.0002). The intraoperative component of the endpoint was met less frequently by Quad group patients (6.26% Quad vs. 12.1% BiP), whereas there was no difference for the post-operative component (7.1% Quad vs. 7.6% BiP). Conclusions The Quartet LV system significantly reduced total LV lead-related events at 6 months after implantation compared with a bipolar CRT system. The reduction in events demonstrates the superiority of this quadripolar technology to effectively manage CRT patients. (More Options Available With a Quadripolar LV Lead Provide In-Clinic Solutions to CRT Challenges [MORE-CRT]; NCT01510652).
2016
11-nov-2015
2
2
212
220
Cardiac Resynchronization Therapy with a Quadripolar Electrode Lead Decreases Complications at 6 Months Results of the MORE-CRT Randomized Trial / Boriani, Giuseppe; Connors, Sean; Kalarus, Zbigniew; Lemke, Bernd; Mullens, Wilfried; Osca Asensi, Joaquin; Raatikainen, Pekka; Gazzola, Carlo; Farazi, Taraneh G.; Leclercq, Christophe. - In: JACC. CLINICAL ELECTROPHYSIOLOGY. - ISSN 2405-500X. - 2:2(2016), pp. 212-220. [10.1016/j.jacep.2015.10.004]
Boriani, Giuseppe; Connors, Sean; Kalarus, Zbigniew; Lemke, Bernd; Mullens, Wilfried; Osca Asensi, Joaquin; Raatikainen, Pekka; Gazzola, Carlo; Farazi, Taraneh G.; Leclercq, Christophe
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2405500X15003679-main.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 781.42 kB
Formato Adobe PDF
781.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1140272
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 38
  • ???jsp.display-item.citation.isi??? ND
social impact